Abbott is the proprietor of a patent describing a continuous glucose monitoring device and a method of assembling the same. SiBio provide devices for continuous ketone monitoring, and Abbott were concerned that they were about to launch a new product that would...
Background The Claimant, Agathon, was the proprietor of a European patent relating to a mechanical system designed to improve alignment in industrial machinery. Particularly, the invention concerns the repeated opening and closing of heavy metal components where...
Background: Long-Arm Jurisdiction The Unified Patent Court (“UPC”) was introduced as a central forum for enforcing European patents across the European Union (“EU”). However, not all EU Member States (e.g. Spain) signed up to the UPC Agreement (“UPCA”), and some...
To briefly recap the key events leading up to this decision, the US Supreme Court found a lack of enablement when assessing the PCSK9 antibody claims in Amgen’s US patent and the Munich Central Division of the UPC initially revoked the European equivalent based on...
Background The UPC Court of Appeal’s decision in Otec v. Steros provides an interesting insight into claim interpretation and the constraints on relying on post-filing experimental evidence at the UPC. The case, UPC Court of Appeal decision 579/2025, arose from a...
This case is part of the international proceedings between Sanofi and Regeneron in relation to the injected monoclonal antibody Repatha (“evolocumab”). Repatha/evolocumab acts by targeting a protein called PCSK9 which binds to low density lipoprotein (LDL) receptors...
Recent Comments